PHASE I STUDIES OF PYRAZOLE (NSC-45410).
D000410:Alanine Transaminase; D000970:Antineoplastic Agents; D001219:Aspartate Aminotransferases; D001769:Blood; D001806:Blood Urea Nitrogen; D004358:Drug Therapy; D007970:Leukopenia; D051379:Mice; D011720:Pyrazoles; D013921:Thrombocytopenia; D014116:Toxicology; D014508:Urea; D014839:Vomiting
D000970:Antineoplastic Agents; D011720:Pyrazoles; C031280:pyrazole; D014508:Urea; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASE; BLOOD; BLOOD UREA NITROGEN; DRUG THERAPY; LEUKOPENIA; MICE; PYRAZOLES; THROMBOPENIA; TOXICOLOGIC REPORT; UREA; VOMITING